Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT07517276

TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index

This is a randomized, double-blind, placebo-controlled Phase 2 proof-of-concept trial in mother-infant dyads. The study aims to evaluate the safety, tolerabilit…

Location not specified80 participantsStarted 2026-04-02

Treatment: tauroursodeoxycholic acid (TUDCA), Placebo